tirzepatide loose stool and Bowel Movements: Managing Digestive Effects The Link Between Tirzepatide and

Eli Lilly and Company is the pharmaceutical company that makes two tirzepatide products that are approved by the Food and Drug Administration (FDA): Mounjaro, which is approved by the FDA for improving blood sugar levels in people with Type 2 diabetes, and is often prescribed off-label for weight loss Zepbound, which is FDA approved for weight loss, as well as for obstructive sleep apnea in adults with obesity Currently, there are no FDA-approved generic versions of the drugs Mounjaro or Zepbound, and there are not any other FDA-approved tirzepatide products available besides brand-name Mounjaro and Zepbound

doi:10.1038/nature22393 211

placebo), with the higher dose not reaching statistical significance

Cystine Transporter SLC7A11/xCT in Cancer: Ferroptosis, Nutrient Dependency, and Cancer Therapy